首页> 外文期刊>Pharmacological reviews >Synaptic Vesicle-Recycling Machinery Components as Potential Therapeutic Targets
【24h】

Synaptic Vesicle-Recycling Machinery Components as Potential Therapeutic Targets

机译:突触囊泡 - 回收机械组件作为潜在的治疗目标

获取原文
获取原文并翻译 | 示例
           

摘要

Presynaptic nerve terminals are highly specialized vesicle-traffickingmachines. Neurotransmitter release from these terminals is sustained by constant local recycling of synaptic vesicles independent from the neuronal cell body. This independence places significant constraints on maintenance of synaptic protein complexes and scaffolds. Key events during the synaptic vesicle cycle-such as exocytosis and endocytosis-require formation and disassembly of protein complexes. This extremely dynamic environment poses unique challenges for proteostasis at synaptic terminals. Therefore, it is not surprising that subtle alterations in synaptic vesicle cycleassociated proteins directly or indirectly contribute to pathophysiology seen in several neurologic and psychiatric diseases. In contrast to the increasing number of examples inwhich presynaptic dysfunction causes neurologic symptoms or cognitive deficits associated with multiple brain disorders, synaptic vesicle-recycling machinery remains an underexplored drug target. In addition, irrespective of the involvement of presynaptic function in the disease process, presynaptic machinery may also prove to be a viable therapeutic target because subtle alterations in the neurotransmitter releasemaycounter diseasemechanisms, correct, or compensate for synaptic communication deficits without the need to interfere with postsynaptic receptor signaling. In this article, we will overview critical properties of presynaptic release machinery to help elucidate novel presynaptic avenues for the development of therapeutic strategies against neurologic and neuropsychiatric disorders.
机译:突触前神经终端是高度专业化的囊泡贩运。从这些终端的神经递质释放由恒定的局部回收突触囊泡无关,突触囊泡独立于神经元细胞体来维持。这种独立性对突触蛋白复合物和支架的维持来说是显着的限制。突触囊泡循环期间的关键事件 - 例如外尿精和内吞作用 - 需要蛋白质复合物的形成和拆卸。这种极其动态的环境对突触终端的蛋白质造成了独特的挑战。因此,在几种神经系统和精神病疾病中,突触囊泡环囊偶联蛋白直接或间接有助于病理生理学的细微改变并不令人惊讶。与越来越多的例子越来越多的突触前功能障碍导致与多种脑疾病相关的神经系统症状或认知缺陷,突触囊泡 - 回收机制仍然是望远镜的药物靶标。此外,无论突触前功能是否在疾病过程中,突触前机械也可能被证明是一种可行的治疗目标,因为神经递质的细微改变是神经递质的细微改变,无需干扰突触的突触通信赤字受体信号传导。在本文中,我们将概述预先突触式发布机制的关键属性,以帮助阐明新的突触前途径,以便于针对神经系统和神经精神疾病的治疗策略的发展。

著录项

  • 来源
    《Pharmacological reviews》 |2017年第2期|共20页
  • 作者

    Li Ying C.; Kavalali Ege T.;

  • 作者单位

    Univ Texas Southwestern Med Ctr Dallas Dept Neurosci 5323 Harry Hines Blvd Dallas TX 75390 USA;

    Univ Texas Southwestern Med Ctr Dallas Dept Neurosci 5323 Harry Hines Blvd Dallas TX 75390 USA;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 药理学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号